11/4/2022 12:13:35 PM - Gapped up on 11/01/22 hitting a new 52-week high on M&A news with Johnson & Johnson (JNJ). Fundamental concerns remain. It was dropped from the Featured Stocks list on 10/19/18.
11/3/2022 12:05:01 PM - Gapped up on 11/01/22 hitting a new 52-week high on M&A news with Johnson & Johnson (JNJ). Fundamental concerns remain. It was dropped from the Featured Stocks list on 10/19/18.
11/2/2022 12:03:29 PM - Gapped up on the prior session hitting a new 52-week high on M&A news with Johnson & Johnson (JNJ). Fundamental concerns remain. It was dropped from the Featured Stocks list on 10/19/18.
2/3/2021 12:18:09 PM - Pulling back after hitting a new 52-week high last week. Fundamental concerns remain. It was dropped from the Featured Stocks list on 10/19/18.
12/29/2020 12:31:42 PM - Hitting a new 52-week high. Fundamental concerns remain. It was dropped from the Featured Stocks list on 10/19/18.
10/19/2018 6:31:20 PM - Slumped further below its 50 DMA line ($392) and ended near the session low with a big loss today on higher volume. It will be dropped from the Featured Stocks list tonight.
10/12/2018 5:42:27 PM - G - Posted a gain today with above average volume, breaking a streak of 9 consecutive losses. A prompt rebound above the 50 DMA line ($391) would help its outlook improve.
10/10/2018 5:36:51 PM - G - Color code is changed to green after slumping below its 50 DMA line ($391) with higher volume behind today's 8th consecutive loss. Only a prompt rebound above the 50 DMA line would help its outlook improve.
10/8/2018 7:03:29 PM - Y - Tallied 6 consecutive losses since a "negative reversal" on 10/01/18 at its all-time high. Its 50 DMA line ($390) defines important support.
10/2/2018 12:08:18 PM - Y - Stalled after a recent 7 session winning streak reaching a new all-time high. Color code was changed to yellow with new pivot point cited based on its 6/20/18 high plus 10 cents in the 9/25/18 mid-day report. Subsequent gains for a new high (N criteria) above the pivot point backed by at least +40% above average volume may trigger a technical buy signal. Reported Jun '18 quarterly earnings +73% on +36% sales revenues. The past 7 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history was noted as a concern, yet its growth rate afterward has been great.
10/2/2018 11:10:34 AM - Y - Stalled after a 7 session winning streak reaching a new all-time high. Color code was changed to yellow with new pivot point cited based on its 6/20/18 high plus 10 cents in the 9/25/18 mid-day report. Subsequent gains for a new high (N criteria) above the pivot point backed by at least +40% above average volume may trigger a technical buy signal. Reported Jun '18 quarterly earnings +73% on +36% sales revenues. The past 7 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history was noted as a concern, yet its growth rate afterward has been great.
9/25/2018 6:29:02 PM - Y - Finished strong today with above average volume behind a 3rd consecutive gain in a 6 session winning streak. Color code was changed to yellow with new pivot point cited based on its 6/20/18 high plus 10 cents in the earlier mid-day report. Subsequent gains for a new high (N criteria) above the pivot point backed by at least +40% above average volume may trigger a technical buy signal. Reported Jun '18 quarterly earnings +73% on +36% sales revenues. The past 7 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history was noted as a concern, yet its growth rate afterward has been great. See the latest FSU analysis for more details and a new annotated graph.
9/25/2018 12:46:07 PM - Y - Color code is changed to yellow with new pivot point cited based on its 6/20/18 high plus 10 cents. Quickly rebounding after a choppy consolidation with volume-driven gains challenging its all-time high. Subsequent gains for a new high (N criteria) above the pivot point backed by at least +40% above average volume may trigger a technical buy signal. Reported Jun '18 quarterly earnings +73% on +36% sales revenues. The past 7 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history was noted as a concern, yet its growth rate afterward has been great.
9/24/2018 12:02:26 PM - Rebounding above its 50 DMA line ($387). Faces resistance due to overhead supply up to the $450 area while rebounding toward its all-time high. Reported Jun '18 quarterly earnings +73% on +36% sales revenues. The past 7 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great.
5/31/2018 12:22:03 PM - Perched at its all-time high, very extended from any sound base. Noted in prior mid-day reports - "Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great."
5/30/2018 12:13:22 PM - Perched at its all-time high, very extended from any sound base. Noted in prior mid-day reports - "Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great."
5/29/2018 12:03:43 PM - Powered to new all-time highs, and it is extended from any sound base. Noted in prior mid-day reports - "Recently found support when testing its 50 DMA line. Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great."
5/18/2018 12:16:44 PM - Powered to new all-time highs, and it is extended from any sound base. Noted in prior mid-day reports - "Recently found support when testing its 50 DMA line. Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great."
5/7/2018 12:43:15 PM - Powered to new all-time highs with volume-driven gains last week, Noted in prior mid-day reports - "Recently found support when testing its 50 DMA line. Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great."
5/4/2018 12:05:16 PM - Powering to new all-time highs with today's 2nd big volume-driven gain, Recently found support when testing its 50 DMA line. Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great.
5/3/2018 12:21:03 PM - Powering to a new all-time high with today's big volume-driven gain, Recently found support when testing its 50 DMA line. Reported Mar '18 quarterly earnings +100% on +40% sales revenues. The past 6 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great.
5/2/2018 12:11:42 PM - Pulling back today after wedging up to touch a new all-time high, Recently found support when testing its 50 DMA line. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Due to report earnings news before the open on Thursday, May 3, 2018. Reported Dec '17 quarterly earnings +106% on +34% sales revenues. The past 5 quarterly comparisons had earnings above the +25% minimum guideline (C criteria).
4/25/2018 12:43:24 PM - Pulled back after wedging up last week to touch a new all-time high, testing its 50 DMA line today. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Dec '17 quarterly earnings +106% on +34% sales revenues. The past 5 quarterly comparisons had earnings above the +25% minimum guideline (C criteria).
2/14/2018 12:28:17 PM - Perched near its all-time high. Very extended from any sound base. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Dec '17 quarterly earnings +106% on +34% sales revenues. The past 5 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
2/6/2018 12:38:40 PM - Pulling back after hitting a new all-time high last week. Very extended from any sound base. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Dec '17 quarterly earnings +106% on +34% sales revenues. The past 5 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
2/5/2018 1:15:04 PM - Perched near its all-time high, very extended from any sound base. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Dec '17 quarterly earnings +106% on +34% sales revenues. The past 5 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
2/1/2018 12:23:43 PM - Hitting a new all-time high, very extended from any sound base. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Dec '17 quarterly earnings +106% on +34% sales revenues. The past 5 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
11/28/2017 12:22:43 PM - Hovering at its all-time high, extended from any sound base. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Sep '17 quarterly earnings +120% on +29% sales revenues. The past 4 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
10/26/2017 12:38:33 PM - Churning near its all-time high following an advanced "3 weeks tight" base. Found prompt support near its 50 DMA line during its ongoing ascent. Downturn in FY '14 annual earnings (A criteria) history is a concern, but growth rate afterward has been great. Reported Sep '17 quarterly earnings +120% on +29% sales revenues. The past 4 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
9/29/2017 12:17:31 PM - Hitting a new all-time high today, and it recently wedged into new all-time high territory with gains lacking great volume conviction. Found prompt support after undercutting its 50 DMA line during its ongoing ascent. Last noted with caution in the 9/05/17 mid-day report - "Reported Jun '17 quarterly earnings +55% on +29% sales revenues. The past 3 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14."
9/5/2017 11:48:54 AM - Consolidating near its all-time high, it found prompt support after undercutting its 50 DMA line ($147) last week. Wedged higher with gains lacking great volume conviction since noted with caution in the 7/27/17 mid-day report - "Reported Jun '17 quarterly earnings +55% on +29% sales revenues. The past 3 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14."
8/30/2017 12:06:54 PM - Pulling back from its all-time high, it violated its 50 DMA line ($146.98) with a gap down on the prior session. Wedged higher with gains lacking great volume conviction since noted with caution in the 7/27/17 mid-day report - "Reported Jun '17 quarterly earnings +55% on +29% sales revenues. The past 3 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14."
8/29/2017 12:31:54 PM - Pulling back from its all-time high, violating its 50 DMA line ($146.98) with a gap down today. Wedged higher with gains lacking great volume conviction since last noted with caution in the 7/27/17 mid-day report - "Reported Jun '17 quarterly earnings +55% on +29% sales revenues. The past 3 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14."
7/27/2017 1:06:24 PM - Reported Jun '17 quarterly earnings +55% on +29% sales revenues. Pulling back from its all-time high toward its 50 DMA line. The past 3 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14.
7/26/2017 12:22:44 PM - Due to report Jun '17 quarterly earnings news on 7/27/17. Perched at its all-time high and making steady progress above its 50 DMA line since last noted with caution in the 5/04/17 mid-day report - "Reported earnings +67% on +33% sales revenues versus the year ago period ended March 31. Three of the past 4 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14."
5/4/2017 12:14:19 PM - Pulling back for a 2nd session after reaching new all-time highs, rebounding after testing its 50 DMA line earlier today. Reported earnings +67% on +33% sales revenues versus the year ago period ended March 31. Three of the past 4 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been improving after a downturn in FY '14.
10/20/2016 12:27:24 PM - Pulling back from all-time highs, testing its 50 DMA line today. The 9/29/16 mid-day report cautioned - "Reported earnings +45% on +40% sales revenues versus the year ago period ended June 30th. Fundamental concerns remain. Up and down quarterly and annual earnings (C and A criteria) history is not a match with the investment system's guidelines."
9/29/2016 12:13:17 PM - Perched at new 52-week and all-time highs. Reported earnings +45% on +40% sales revenues versus the year ago period ended June 30th. Fundamental concerns remain. Up and down quarterly and annual earnings (C and A criteria) history is not a match with the investment system's guidelines.
9/27/2016 12:12:43 PM - Hitting new 52-week and all-time highs. Reported earnings +45% on +40% sales revenues versus the year ago period ended June 30th. Fundamental concerns remain. Noted with caution in prior mid-day reports - "Up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
5/3/2016 12:14:44 PM - Perched within striking distance of its 52-week high. Reported earnings -23% on +38% sales revenues versus the year ago period ended Dec 31st. Fundamental concerns remain as when last noted with caution in the 8/14/15 mid-day report - "Up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
8/14/2015 12:33:54 PM - Pulling back today after hitting another new 52-week high on the prior session. Very extended from any sound base following volume-driven gains after rising from a cup shaped base. Prior mid-day reports cautioned members - "Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
8/13/2015 12:15:25 PM - Hitting another new 52-week high today. Very extended from any sound base following volume-driven gains after rising from a cup shaped base. Prior mid-day reports cautioned members - "Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
8/12/2015 12:15:41 PM - Touched another new 52-week high today. Very extended from any sound base following volume-driven gains after rising from a cup shaped base. Prior mid-day reports cautioned members - "Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
8/11/2015 12:26:56 PM - Trading up today following a "negative reversal" at its 52-week high on the prior session. Extended from any sound base following 4 consecutive volume-driven gains after recently rising from a cup shaped base. Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
8/10/2015 9:21:51 PM - There was a "negative reversal" today at its 52-week high after getting extended from any sound base following 4 consecutive volume-driven gains. Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. Built a cup shaped base and broke out last week. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
8/7/2015 12:31:27 PM - Perched at its 52-week high today, extended from any sound base following 3 consecutive volume-driven gains. Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. Built a cup shaped base and broke out last week. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
8/6/2015 12:19:06 PM - Hitting another new 52-week high with today's 3rd consecutive volume-driven gain. Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. Built a cup shaped base and broke out last week. Previously noted with caution -"On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
8/4/2015 12:12:28 PM - Gapped up today for a new 52-week high. Reported earnings of 20 cents per share versus a loss of 4 cents per share on +50% sales versus the year ago period ended June 30th, but fundamental concerns remain. Built a cup shaped base and broke out last week. Last noted with caution on 5/07/15 -"On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines."
5/7/2015 12:13:38 PM - Making its 3rd consecutive mid-day report appearance, pulling back following a 5/05/15 gap up and considerable gain for a new 52-week high. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
5/6/2015 12:25:35 PM - Making its 2nd consecutive mid-day report appearance, pulling back today, following a gap up and considerable gain for a new 52-week high on the prior session. Noted on 3/24/15 when gapping up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
5/5/2015 12:12:08 PM - Gapped up today for a new 52-week high. Consolidated since last noted on 3/24/15 when gapping up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
3/24/2015 12:09:59 PM - Gapped up today for a new 52-week high on FDA approval of its heart pump. Reported strong Sep and Dec '14 earnings but fundamental concerns remain as noted in prior mid-day reports - "Earnings history is not a match with the investment system's guidelines."
1/29/2015 12:25:14 PM - Perched at a new 52-week high today after a considerable gap up gain on the prior session following strong Dec '14 earnings news. Fundamental concerns remain as noted in prior mid-day reports - "Earnings history is not a match with the investment system's guidelines."
5/16/2012 12:33:35 PM - Encountering distributional pressure after gapping up today and hitting a new 52-week high. Reported earnings versus year-ago losses or minuscule earnings in the 3 latest quarterly comparisons through Mar '12. Following years of losses it has produced earnings in its FY '12, however consensus estimates for FY '13 are calling for earnings -20%. Noted in prior mid-day reports - "Earnings history is not a match with the investment system's guidelines."
5/14/2012 12:02:44 PM - Consolidating above its 50 DMA line after recently encountering distributional pressure. The 5/01/12 mid-day report noted - "Touched a new 52-week high today. Found support near its 50 DMA line during its choppy consolidation since last noted in the 2/10/12 mid-day report - 'Earnings history is not a match with the investment system's guidelines.'"
5/1/2012 11:48:01 AM - Touched a new 52-week high today. Found support near its 50 DMA line during its choppy consolidation since last noted in the 2/10/12 mid-day report - "Earnings history is not a match with the investment system's guidelines."
2/10/2012 11:42:29 AM - Hovering at its 52-week high today, holding its ground following volume-driven gains. Prior mid-day reports noted - "Earnings history is not a match with the investment system's guidelines."
2/8/2012 12:00:49 PM - Hovering at its 52-week high today. It tallied 5 consecutive volume-driven gains when last noted in the 2/06/12 mid-day report. Earnings history is not a match with the investment system's guidelines.
2/6/2012 12:19:37 PM - Hit a new 52-week high with today's 5th consecutive volume-driven gain. Earnings history is not a match with the investment system's guidelines.